Clinical study on the retraction time after preventive ileostomy in middle and low rectal cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032585

Enrollment

Unknown

Registered

2020-05-03

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

15 days group:Retraction will be performed at 15 days after prophylactic stoma

3 months group:Retraction will be performed at 3 months after prophylactic stoma

3 months group:Retraction will be performed at 6 months after prophylactic stoma

15 days group(postoperative adjuvant treatment):Retraction will be performed at 15 days after prophylactic stoma to the patients requiring postoperative chemotherapy

3 months group (postoperative adjuvant treatment):Retraction will be performed at 3 months after prophylactic stoma to the patients requiring postoperative chemotherapy

6 months group (postoperative adjuvant treatment):Retraction will be performed at 6 months after prophylactic stoma to the patients requiring postoperative chemotherapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with middle and low rectal cancer (CT shows that the tumor is located below the peritoneal reflex; colonoscopy shows that the lower edge of the tumor is more than 3 cm within 10 cm of the dentate line). 2. Patients undergoing radical resection of rectal cancer with prophylactic stoma, no signs of anastomotic leakage during perioperative period. 3. TNM staging is I-III. 4. Age is between 18 years old. 5. The retraction time is less than six months from the last ostomy. 6. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. No radical resection. 2. Patients with severe cardiopulmonary dysfunction can not tolerate secondary surgery or tumor recurrence or metastasis is found before surgery.

Design outcomes

Primary

Measure	Time frame
Ostomy complications;Anal functional exercise score;Ostomy retraction rate;Early complications of surgery;Late complications of surgery;Timing of chemotherapy;Medical expenses;	—

Secondary

Measure	Time frame
ESCA;OAS;PSSS;	—

Countries

China

Contacts

Public ContactZhou Jianping

The First Hospital, China Medical University

zjphama@163.com+86 13840509519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026